nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobupivacaine—CYP1A2—Thalidomide—leprosy	0.27	0.345	CbGbCtD
Levobupivacaine—CYP1A2—Rifampicin—leprosy	0.261	0.335	CbGbCtD
Levobupivacaine—CYP3A4—Rifampicin—leprosy	0.137	0.175	CbGbCtD
Levobupivacaine—CYP3A4—Dapsone—leprosy	0.113	0.145	CbGbCtD
Levobupivacaine—Swelling face—Dapsone—leprosy	0.0107	0.0491	CcSEcCtD
Levobupivacaine—Circumoral paresthesia—Thalidomide—leprosy	0.00802	0.0367	CcSEcCtD
Levobupivacaine—Meningitis—Thalidomide—leprosy	0.00674	0.0309	CcSEcCtD
Levobupivacaine—Dysaesthesia—Thalidomide—leprosy	0.00605	0.0277	CcSEcCtD
Levobupivacaine—Paraesthesia oral—Thalidomide—leprosy	0.00558	0.0255	CcSEcCtD
Levobupivacaine—Neck stiffness—Thalidomide—leprosy	0.00549	0.0251	CcSEcCtD
Levobupivacaine—Sinus bradycardia—Thalidomide—leprosy	0.00533	0.0244	CcSEcCtD
Levobupivacaine—Nuchal rigidity—Thalidomide—leprosy	0.00504	0.0231	CcSEcCtD
Levobupivacaine—Enlargement abdomen—Thalidomide—leprosy	0.00435	0.0199	CcSEcCtD
Levobupivacaine—Muscular weakness—Dapsone—leprosy	0.00327	0.015	CcSEcCtD
Levobupivacaine—Numbness—Thalidomide—leprosy	0.00315	0.0144	CcSEcCtD
Levobupivacaine—Apnoea—Thalidomide—leprosy	0.00308	0.0141	CcSEcCtD
Levobupivacaine—Sensory loss—Thalidomide—leprosy	0.00302	0.0138	CcSEcCtD
Levobupivacaine—Musculoskeletal stiffness—Thalidomide—leprosy	0.00291	0.0133	CcSEcCtD
Levobupivacaine—Skin discolouration—Thalidomide—leprosy	0.0029	0.0133	CcSEcCtD
Levobupivacaine—Bone disorder—Thalidomide—leprosy	0.0029	0.0133	CcSEcCtD
Levobupivacaine—Hypocalcaemia—Thalidomide—leprosy	0.00286	0.0131	CcSEcCtD
Levobupivacaine—Neuropathy peripheral—Dapsone—leprosy	0.0028	0.0128	CcSEcCtD
Levobupivacaine—Leukocytosis—Thalidomide—leprosy	0.00278	0.0127	CcSEcCtD
Levobupivacaine—Atrioventricular block—Thalidomide—leprosy	0.0027	0.0123	CcSEcCtD
Levobupivacaine—Neck pain—Thalidomide—leprosy	0.00265	0.0121	CcSEcCtD
Levobupivacaine—Hyperkalaemia—Thalidomide—leprosy	0.00257	0.0118	CcSEcCtD
Levobupivacaine—Depressed level of consciousness—Thalidomide—leprosy	0.00253	0.0116	CcSEcCtD
Levobupivacaine—Neuropathy—Thalidomide—leprosy	0.00246	0.0112	CcSEcCtD
Levobupivacaine—Tinnitus—Dapsone—leprosy	0.00239	0.0109	CcSEcCtD
Levobupivacaine—Lightheadedness—Thalidomide—leprosy	0.00234	0.0107	CcSEcCtD
Levobupivacaine—Pulmonary oedema—Thalidomide—leprosy	0.00233	0.0107	CcSEcCtD
Levobupivacaine—Euphoric mood—Thalidomide—leprosy	0.00225	0.0103	CcSEcCtD
Levobupivacaine—Erythema—Dapsone—leprosy	0.00223	0.0102	CcSEcCtD
Levobupivacaine—Vascular purpura—Thalidomide—leprosy	0.00212	0.00971	CcSEcCtD
Levobupivacaine—Vision blurred—Dapsone—leprosy	0.0021	0.00963	CcSEcCtD
Levobupivacaine—Injury—Thalidomide—leprosy	0.00207	0.00945	CcSEcCtD
Levobupivacaine—Purpura—Thalidomide—leprosy	0.00197	0.00901	CcSEcCtD
Levobupivacaine—Cough—Dapsone—leprosy	0.00195	0.00892	CcSEcCtD
Levobupivacaine—Lethargy—Thalidomide—leprosy	0.00194	0.00887	CcSEcCtD
Levobupivacaine—Diplopia—Thalidomide—leprosy	0.0019	0.00869	CcSEcCtD
Levobupivacaine—Osteoarthritis—Thalidomide—leprosy	0.0019	0.00869	CcSEcCtD
Levobupivacaine—Cardiac arrest—Thalidomide—leprosy	0.0018	0.00826	CcSEcCtD
Levobupivacaine—Tachycardia—Dapsone—leprosy	0.00178	0.00814	CcSEcCtD
Levobupivacaine—Blood creatinine increased—Thalidomide—leprosy	0.00178	0.00814	CcSEcCtD
Levobupivacaine—Orthostatic hypotension—Thalidomide—leprosy	0.00173	0.00794	CcSEcCtD
Levobupivacaine—Aspartate aminotransferase increased—Thalidomide—leprosy	0.00171	0.00782	CcSEcCtD
Levobupivacaine—Muscular weakness—Thalidomide—leprosy	0.00167	0.00766	CcSEcCtD
Levobupivacaine—Alanine aminotransferase increased—Thalidomide—leprosy	0.00167	0.00766	CcSEcCtD
Levobupivacaine—Abdominal distension—Thalidomide—leprosy	0.00165	0.00756	CcSEcCtD
Levobupivacaine—Insomnia—Dapsone—leprosy	0.00165	0.00754	CcSEcCtD
Levobupivacaine—Dysphagia—Thalidomide—leprosy	0.00164	0.00751	CcSEcCtD
Levobupivacaine—Bronchospasm—Thalidomide—leprosy	0.00161	0.00739	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Dapsone—leprosy	0.00149	0.00682	CcSEcCtD
Levobupivacaine—Infestation NOS—Thalidomide—leprosy	0.00146	0.0067	CcSEcCtD
Levobupivacaine—Infestation—Thalidomide—leprosy	0.00146	0.0067	CcSEcCtD
Levobupivacaine—Drowsiness—Thalidomide—leprosy	0.00146	0.0067	CcSEcCtD
Levobupivacaine—Abdominal pain—Dapsone—leprosy	0.00144	0.00659	CcSEcCtD
Levobupivacaine—Body temperature increased—Dapsone—leprosy	0.00144	0.00659	CcSEcCtD
Levobupivacaine—Neuropathy peripheral—Thalidomide—leprosy	0.00143	0.00656	CcSEcCtD
Levobupivacaine—Sweating—Thalidomide—leprosy	0.0014	0.00642	CcSEcCtD
Levobupivacaine—Haematuria—Thalidomide—leprosy	0.00139	0.00638	CcSEcCtD
Levobupivacaine—Bradycardia—Thalidomide—leprosy	0.00134	0.00612	CcSEcCtD
Levobupivacaine—Hypoaesthesia—Thalidomide—leprosy	0.00131	0.00598	CcSEcCtD
Levobupivacaine—Oedema peripheral—Thalidomide—leprosy	0.00129	0.00592	CcSEcCtD
Levobupivacaine—Tinnitus—Thalidomide—leprosy	0.00122	0.0056	CcSEcCtD
Levobupivacaine—Cardiac disorder—Thalidomide—leprosy	0.00122	0.00558	CcSEcCtD
Levobupivacaine—Chills—Thalidomide—leprosy	0.00118	0.00539	CcSEcCtD
Levobupivacaine—Arrhythmia—Thalidomide—leprosy	0.00117	0.00537	CcSEcCtD
Levobupivacaine—Vomiting—Dapsone—leprosy	0.00116	0.0053	CcSEcCtD
Levobupivacaine—Mental disorder—Thalidomide—leprosy	0.00115	0.00527	CcSEcCtD
Levobupivacaine—Malnutrition—Thalidomide—leprosy	0.00114	0.00523	CcSEcCtD
Levobupivacaine—Headache—Dapsone—leprosy	0.00114	0.00523	CcSEcCtD
Levobupivacaine—Flatulence—Thalidomide—leprosy	0.00113	0.00516	CcSEcCtD
Levobupivacaine—Tension—Thalidomide—leprosy	0.00112	0.00513	CcSEcCtD
Levobupivacaine—Nervousness—Thalidomide—leprosy	0.00111	0.00508	CcSEcCtD
Levobupivacaine—Back pain—Thalidomide—leprosy	0.00111	0.00506	CcSEcCtD
Levobupivacaine—Muscle spasms—Thalidomide—leprosy	0.0011	0.00503	CcSEcCtD
Levobupivacaine—Nausea—Dapsone—leprosy	0.00108	0.00495	CcSEcCtD
Levobupivacaine—Vision blurred—Thalidomide—leprosy	0.00108	0.00493	CcSEcCtD
Levobupivacaine—Tremor—Thalidomide—leprosy	0.00107	0.0049	CcSEcCtD
Levobupivacaine—Anaemia—Thalidomide—leprosy	0.00106	0.00484	CcSEcCtD
Levobupivacaine—Agitation—Thalidomide—leprosy	0.00105	0.00481	CcSEcCtD
Levobupivacaine—Angioedema—Thalidomide—leprosy	0.00104	0.00478	CcSEcCtD
Levobupivacaine—Syncope—Thalidomide—leprosy	0.00103	0.00469	CcSEcCtD
Levobupivacaine—Palpitations—Thalidomide—leprosy	0.00101	0.00462	CcSEcCtD
Levobupivacaine—Loss of consciousness—Thalidomide—leprosy	0.001	0.0046	CcSEcCtD
Levobupivacaine—Cough—Thalidomide—leprosy	0.000998	0.00457	CcSEcCtD
Levobupivacaine—Convulsion—Thalidomide—leprosy	0.00099	0.00453	CcSEcCtD
Levobupivacaine—Hypertension—Thalidomide—leprosy	0.000987	0.00452	CcSEcCtD
Levobupivacaine—Arthralgia—Thalidomide—leprosy	0.000973	0.00445	CcSEcCtD
Levobupivacaine—Anxiety—Thalidomide—leprosy	0.00097	0.00444	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000967	0.00442	CcSEcCtD
Levobupivacaine—Confusional state—Thalidomide—leprosy	0.000941	0.00431	CcSEcCtD
Levobupivacaine—Oedema—Thalidomide—leprosy	0.000933	0.00427	CcSEcCtD
Levobupivacaine—Infection—Thalidomide—leprosy	0.000927	0.00424	CcSEcCtD
Levobupivacaine—Shock—Thalidomide—leprosy	0.000918	0.0042	CcSEcCtD
Levobupivacaine—Nervous system disorder—Thalidomide—leprosy	0.000915	0.00419	CcSEcCtD
Levobupivacaine—Tachycardia—Thalidomide—leprosy	0.000911	0.00417	CcSEcCtD
Levobupivacaine—Skin disorder—Thalidomide—leprosy	0.000906	0.00415	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Thalidomide—leprosy	0.000902	0.00413	CcSEcCtD
Levobupivacaine—Hypotension—Thalidomide—leprosy	0.000872	0.00399	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Thalidomide—leprosy	0.00085	0.00389	CcSEcCtD
Levobupivacaine—Insomnia—Thalidomide—leprosy	0.000844	0.00386	CcSEcCtD
Levobupivacaine—Paraesthesia—Thalidomide—leprosy	0.000838	0.00383	CcSEcCtD
Levobupivacaine—Dyspnoea—Thalidomide—leprosy	0.000832	0.00381	CcSEcCtD
Levobupivacaine—Somnolence—Thalidomide—leprosy	0.000829	0.0038	CcSEcCtD
Levobupivacaine—Dyspepsia—Thalidomide—leprosy	0.000821	0.00376	CcSEcCtD
Levobupivacaine—Decreased appetite—Thalidomide—leprosy	0.000811	0.00371	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Thalidomide—leprosy	0.000805	0.00369	CcSEcCtD
Levobupivacaine—Pain—Thalidomide—leprosy	0.000798	0.00365	CcSEcCtD
Levobupivacaine—Constipation—Thalidomide—leprosy	0.000798	0.00365	CcSEcCtD
Levobupivacaine—Feeling abnormal—Thalidomide—leprosy	0.000769	0.00352	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Thalidomide—leprosy	0.000763	0.00349	CcSEcCtD
Levobupivacaine—Urticaria—Thalidomide—leprosy	0.000741	0.00339	CcSEcCtD
Levobupivacaine—Abdominal pain—Thalidomide—leprosy	0.000738	0.00338	CcSEcCtD
Levobupivacaine—Body temperature increased—Thalidomide—leprosy	0.000738	0.00338	CcSEcCtD
Levobupivacaine—Hypersensitivity—Thalidomide—leprosy	0.000687	0.00315	CcSEcCtD
Levobupivacaine—Asthenia—Thalidomide—leprosy	0.000669	0.00306	CcSEcCtD
Levobupivacaine—Pruritus—Thalidomide—leprosy	0.00066	0.00302	CcSEcCtD
Levobupivacaine—Diarrhoea—Thalidomide—leprosy	0.000638	0.00292	CcSEcCtD
Levobupivacaine—Dizziness—Thalidomide—leprosy	0.000617	0.00282	CcSEcCtD
Levobupivacaine—Vomiting—Thalidomide—leprosy	0.000593	0.00272	CcSEcCtD
Levobupivacaine—Headache—Thalidomide—leprosy	0.000584	0.00268	CcSEcCtD
Levobupivacaine—Nausea—Thalidomide—leprosy	0.000554	0.00254	CcSEcCtD
